Intranasal Corticosteroid Selection for Sinus Congestion

Evidence-Based Recommendations

The European Position Paper on Rhinosinusitis (EPOS 2020) recommends mometasone furoate nasal spray (MFNS) 200 mcg twice daily for significant reduction in total symptom scores and nasal congestion compared to placebo in multiple large trials 1, 2
The European Position Paper on Rhinosinusitis (EPOS 2020) also recommends fluticasone propionate nasal spray (FPNS) 200 mcg once daily, which showed comparable efficacy with significant improvement in congestion, facial pain, and overall symptom scores 1, 2

All intranasal corticosteroids are similarly effective when used at equipotent doses, according to the Journal of Allergy and Clinical Immunology, and the choice between specific agents is less important than ensuring proper administration and adherence 3, 4
Studies directly comparing MFNS and FPNS found no significant differences in efficacy for nasal congestion relief, as reported in Rhinology 1, 2

Intranasal corticosteroids are the most effective medication class for controlling all four major symptoms of rhinitis, including nasal congestion, according to the Journal of Allergy and Clinical Immunology 3, 4
They provide greater reduction in congestion compared to oral antihistamines alone, as reported in the Journal of Allergy and Clinical Immunology 3

When used at recommended doses, intranasal corticosteroids have minimal systemic effects, with no clinically significant effects on hypothalamic-pituitary-adrenal axis, according to Praxis Medical Insights 5
Local side effects (nasal irritation, bleeding) occur in <5% of patients and can be minimized with proper technique, as reported in Praxis Medical Insights 5

Proper spray technique is essential for efficacy and safety, with the spray directed away from the nasal septum toward the lateral nasal wall to prevent septal irritation and rare perforation, according to the Journal of Allergy and Clinical Immunology 3, 5

For acute post-viral rhinosinusitis, MFNS 200 mcg twice daily or FPNS 200 mcg once daily reduces symptom duration and severity, as reported in Rhinology 1, 2, 7
For chronic rhinosinusitis, intranasal corticosteroids remain first-line medical therapy, according to the Journal of Allergy and Clinical Immunology 6, 8